In what may be one of his final major acts in the White House, President Joe Biden has proposed extending Medicare and Medicaid to cover the costs of anti-obesity drugs increasingly used to help ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal unveiled Tuesday by the Biden administration. Some 3.4 million ...

Taking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, a new study has found. Taking anti-obesity drugs has led some U.S ...

This article describes how diabetes contributes to erectile dysfunction, and how erectile dysfunction is treated in a patient ...

The Biden administration Tuesday announced plans to provide coverage for a class of costly anti-obesity medications including Wegovy and Zepbound for those enrolled in Medicare and Medicaid.

Lieutenant governor (LG) VK Saxena on Tuesday announced a month-long anti-drug campaign starting December 1 with the aim of making the Capital drug-free within the next three years, officials from ...

Alex Zhavoronkov, founder & CEO of Insilico Medicine, stated that he “firmly believes that the repurposing of FDA-approved drugs with demonstrated anti-ageing potential represents a highly ...

Nonsteroidal anti-inflammatory drugs are among the most widely prescribed medications. Their effect on blood pressure has been monitored, and many small studies have determined a potential ...

The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic and Wegovy for people with Medicare and Medicaid through a new proposal from the Department of Health and Human ...

MANILA – The Police Regional Office (PRO) 11 (Davao Region) has confiscated PHP3.8 million worth of illegal drugs and arrested 76 suspects during a series of anti-drug operations from Nov. 11 to 17.

MANILA – The Police Regional Office (PRO) 3 seized over PHP74 million worth of illegal drugs in 910 anti-drug operations across the region from Oct. 1 to Nov. 25 this year. In a statement Wednesday, ...

The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction ...